Trial NCT06083675

View at ClinicalTrials.gov 
Org. Study IDs: NN9924-7663
Secondary IDs: U1111-1291-4976

Last trial update was posted on 2024-02-26

MeSH Interventions

Empagliflozin Metformin Semaglutide

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions


Stopping Reasons

Due to internal reprioritization, trial was cancelled.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID